- Home
- NGVC vs PHAR Comparison
NGVC vs PHAR Comparison
Compare NGVC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGVC
- PHAR
- Stock Information
- Founded
- NGVC 1955
- PHAR 1988
- Country
- NGVC United States
- PHAR Netherlands
- Employees
- NGVC N/A
- PHAR N/A
- Industry
- NGVC Food Chains
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- NGVC Consumer Staples
- PHAR Health Care
- Exchange
- NGVC Nasdaq
- PHAR Nasdaq
- Market Cap
- NGVC 910.4M
- PHAR 798.2M
- IPO Year
- NGVC 2012
- PHAR N/A
- Fundamental
- Price
- NGVC $40.54
- PHAR $13.70
- Analyst Decision
- NGVC
- PHAR Strong Buy
- Analyst Count
- NGVC 0
- PHAR 3
- Target Price
- NGVC N/A
- PHAR $30.00
- AVG Volume (30 Days)
- NGVC 281.2K
- PHAR 12.8K
- Earning Date
- NGVC 08-07-2025
- PHAR 07-31-2025
- Dividend Yield
- NGVC 1.21%
- PHAR N/A
- EPS Growth
- NGVC 40.24
- PHAR N/A
- EPS
- NGVC 1.88
- PHAR N/A
- Revenue
- NGVC $1,317,356,000.00
- PHAR $339,836,000.00
- Revenue This Year
- NGVC $1.32
- PHAR $12.88
- Revenue Next Year
- NGVC N/A
- PHAR $8.54
- P/E Ratio
- NGVC $21.16
- PHAR N/A
- Revenue Growth
- NGVC 8.51
- PHAR 22.44
- 52 Week Low
- NGVC $24.42
- PHAR $6.73
- 52 Week High
- NGVC $61.22
- PHAR $17.08
- Technical
- Relative Strength Index (RSI)
- NGVC 54.72
- PHAR 67.43
- Support Level
- NGVC $39.33
- PHAR $12.13
- Resistance Level
- NGVC $41.32
- PHAR $12.76
- Average True Range (ATR)
- NGVC 2.03
- PHAR 0.89
- MACD
- NGVC 0.32
- PHAR 0.13
- Stochastic Oscillator
- NGVC 47.03
- PHAR 44.41
About NGVC Natural Grocers by Vitamin Cottage Inc.
Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories, natural and organic food, dietary supplements, natural body care, household, pet care products, books and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business are conducted. The company generates the majority of its revenue from grocery products and dietary supplements and rest from other products.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.